Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Researchers at West Virginia University, Mary Babb Randolph Cancer Center have published new data on cancer gene therapy
January 6th, 2009
New research, 'Confirmation of gene expression-based prediction of survival in non-small cell lung cancer,' is the subject of a report. "It is a critical challenge to determine the risk of recurrence in early stage non-small cell lung cancer (NSCLC) patients. Accurate gene expression signatures are needed to classify patients into high-and low-risk groups to improve the selection of patients for adjuvant therapy," researchers in the United States report. "Multiple published microarray data sets were used to evaluate our previously identified lung cancer prognostic gene signature. Expression of the signature genes was further validated with real-time reverse...
Source: Cancer Weekly (2009-01-06)
|
